Publications scientifiques

Vous trouverez ci-dessous une liste des publications scientifiques en lien avec la thématique « maladie rare » 

 

  • Dans la sclérodermie systémique (impliquant notre équipe et uniquement sur 2025-2026)

  • 1. Trottet C, Schürch M, Allam A, Petelytska L, Castellví I, Bečvář R, de Vries-

    Bouwstra J, Iannone F, Carreira P, Truchetet ME, Cuomo G, Rezus E, Cantatore FP,

    Simeón-Aznar CP, Parvu M, Dzhus M, Distler O, Hoffmann-Vold AM, Krauthammer M;

    EUSTAR Collaborators. Deep hierarchical subtyping of multi-organ systemic sclerosis trajectories - a EUSTAR study. NPJ Digit Med. 2025 Sep 1;8(1):563..

  • 2. Moschetti L, Rovaris S, Bonomi F, Codes-Mendez H, Martín-López M,

    Cacciapaglia F, Tonutti A, Galdo FD, Campochiaro C, Truchetet ME, Allanore Y,

    Kuwana M, Bruni C, Santos CS, Moroncini G, Caetano J, Granel B, Groseanu L,

    Pedretti E, Colombo E, Guerini M, Pereira Silva M, Bearzi P, Belloli L, Alegre-

    Sancho JJ, Maglio C, Cuomo G, Parvu M, Poormoghim H, Idolazzi L, Andréasson K,

    De Santis M, Iannone F, Carreira PE, Castellví I, Guiducci S, Cavazzana I,

    Franceschini F, Airò P, Lazzaroni MG. The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohort. Ther Adv Musculoskelet Dis. 2026 Mar 

    2;18:1759720X261422369.

  • 3: Bermudez J, Heim X, Kaspi E, Reytier C, Beziane A, Arcani R, Benyamine A,

    Granel B, Villa A, Blot-Chabaud M, Dumontet E, Paris C, Lescoat A, Lecureur V,

    Bardin N. Anti-CD146 Autoantibodies: The First Biologic Markers Associated With Occupational Exposure in Systemic Sclerosis. ACR Open Rheumatol. 2026 Mar;8(3):e90004.

  • 4: Arcani R, Velier M, Sabatier F, Simoncini S, Abellan-Lopez M, Granel B,

    Benyamine A, Gomes de Pinho Q, Dani V, Gentile P, Magalon G, Menkes S, Sampson

    S, Verpaele A, Vonk L, Magalon J, Daumas A. Nanofat Use in Regenerative Medicine: A Systematic Literature Review and Consensus Recommendations from Expert Opinions. Facial Plast Surg Aesthet Med. 2025 Nov-Dec;27(6):469- 80. doi:10.1089/fpsam.2024.0385. Epub 2025 Apr 18. PMID: 40250993.

  • 5: Barde F, Chevalier K, Decker P, Merin M, Nicolas A, Lescoat A, Deroux A,

    Koether V, Chatelus E, Coustal C, Maria A, Michaud M, Pugnet G, Murarasu A,

    Riviere S, Charles P, de Moreuil C, Lodovichetti J, Maillet F, Renaud A, Granel

    B, Mouthon L, Chaigne B. Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc). J Autoimmun. 2025 Dec;157:103492.

  • 6: Roth E, Bruni C, Petelytska L, Becker MO, Dobrota R, Jordan S, Mihai C,

    Muraru S, Carreira PE, De Vries-Bouwstra J, Braun-Moscovici Y, Liakouli V,

    Moroncini G, Bergmann C, Mouthon L, Denton CP, De Santis M, Cauli A, Adler S,

    Bernardino V, Truchetet ME, Vonk M, Del Galdo F, Hoffmann-Vold AM, Distler O,

    Elhai M; EUSTAR Collaborators. Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort. Rheumatology (Oxford). 2025 Dec 1;64(SI):SI63-SI72.

  • Dans les vascularites (impliquant notre équipe et uniquement sur 2025-2026)

  • 1: Dhrif O, Caudron C, Parreau S, Liozon E, Mirouse A, Alexandra JF, Sailler L,

    Velia C, Groh M, de Boysson H, Ebbo M, Comarmond C, Durel CA, Woessner J, Jarrot

    PA, Didier K, Goulabchand R, Cacoub P, Bonnotte B, Saadoun D, Samson M. Stroke characteristics in giant cell arteritis and Takayasu arteritis: A multicenter retrospective cohort study of 108 patients. Semin Arthritis Rheum. 2026

    Apr;77:152943.    

  • 2: Espitia O, de Boysson H, Heron E, Rodriguez-Regent C, Jousse S, Lapebie FX,

    Gobin-Metteil MP, Morard M, Besson FL, Jamet B, Puechal X, Sailler L, Redheuil

    A, Agard C, Serfaty JM, Gomes de Pinho Q, Seror R, Nguyen Y, Vignal-Clermont C,

    Parreau S, Devauchelle-Pensec V, Lecler A, Saadoun D, Samson M, Regent A; French

    Study Group for Large Vessel Vasculitis (GEFA). French recommendations for the use of imaging in giant cell arteritis. Joint Bone Spine. 2026 May 8;93(5):106073. doi: 10.1016/j.jbspin.2026.106073.

  • 3: Morin J, Jarrot PA, Solignac J, Lefevre F, Brunet P, Kaplanski G, Burtey S,

    Daniel L, Torrents J, Faraut J, Jourde-Chiche N, Bobot M. Infectious complications of ANCA-associated vasculitis: Description and associated outcome. Eur J Intern Med. 2026 May 9:106931. doi: 10.1016/j.ejim.2026.106931. Epub ahead of print. PMID: 42108131.

  • 4: Dib N, Saadoun D, Le Joncour A, Dumas de la Roque C, Pasquier E, Esteve E,

    Marie I, Choukroun G, Quemeneur T, Swiader L, Michel C, Perier A, Bridoux F,

    Thoreau B, Groh M, Terrier B, Zenone T, Launay D, Cacoub P, Mirouse A; CryoVas

    group. Long Term Outcomes in Patients With Non-Infectious Mixed Cryoglobulinemic Vasculitis. Am J Hematol. 2026 May;101(5):1108-1113.

  •  5: Jauzelon B, Pereira Dos Santos T, Roubille C, Dumain C, Singh N, Gomes de

    Pinho Q, Granel B, Mura T, Goulabchand R. Burden of incident cardiovascular events in giant cell arteritis using data from a nationwide French cohort. Sci

    Rep. 2026 Jun 5.

  • 6: Antoniadis J, Benyamine A, Jean E, Jeandel PY, Daumas A, Granel B, Gomes de

    Pinho Q. Atteinte vasculaire inflammatoire sans aortite dans l’artérite à cellules géantes : à propos de 4 cas. Rev Med Interne. 2026 Apr;47(4):224-228. French.

  • 7: Duhamel N, Puéchal X, Le Gallou T, Chezel J, Deroux A, Roussin C, Keraen J,

    De Moreuil C, Jarrot PA, Gerfaud-Valentin M, Maurier F, Campagne J, Melki I,

    Melboucy S, Nagle S, Terrier B, Martis N; French Vasculitis Study Group (Groupe

    Français d’Etude des Vascularites). Glandular Manifestations of the Head and Neck in ANCA-Associated Vasculitides: Data from a National Cohort and Systematic Review. Clin Rev Allergy Immunol. 2025 Oct 15;68(1):90.

  • 8: Antoniadis J, Bobot M, Boittin M, Barral PA, Jacquier A, Kaplanski G, Jourde-

    Chiche N, Jarrot PA. Une artériographie rénale anormale. Rev Med Interne. 2025 Nov;46(11):677-678. French.

 

  • Dans les maladies auto-inflammatoires (impliquant notre équipe et uniquement sur 2025-2026)

  •  1: Mertz P, Elhani I, Koné-Paut I, Dan D, Roque S, Theodoropoulou K, Pachlopnick

    Schmid J, Bader-Menier B, Belot A, Dumaine C, Kevorkian-Verguet C, Cavelot S,

    Georgin-Lavialle S, Hentgen V. Colchicine resistance prediction criteria from the TURPAID cohort do not apply to the JIR cohort: a multicentre descriptive analysis. RMD Open. 2026 Feb 18;12(1):e006409